G. Sutton

发表

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group.

D. Matei, S. Perkins, R. Ramasubbaiah, 2011, Gynecologic oncology.

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.

R. Wendt, D. Mutch, D. Podoloff, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group study

G. Sutton, J. Thigpen, W. Creasman, 1989 .

Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.

G. Sutton, P. Kramer, P. Hanjani, 2005, Gynecologic oncology.

Ifosfamide Treatment of Recurrent or Metastatic Endometrial Stromal Sarcomas Previously Unexposed to Chemotherapy: A Study of the Gynecologic Oncology Group

P. Disaia, G. Sutton, R. Park, 1996, Obstetrics and gynecology.

Vulvar melanoma reconsidered

G. Sutton, K. Look, L. Roth, 1993, Cancer.

Assessment of primary gynecologic malignancies: comparison of 0.15-T resistive MRI with CT.

J. Ellis, K. Kopecky, G. Sutton, 1984, AJR. American journal of roentgenology.

Magnetic resonance imaging in the preoperative assessment of clinical stage I endometrial carcinoma.

K. Kopecky, G. Sutton, C. Harrill, 1990, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.

G. Sutton, J. Hurteau, M. Randall, 1999, Gynecologic oncology.

Peritoneal cytology in endometrial carcinoma.

G. Sutton, 1989, Cancer treatment and research.

Features associated with survival and disease-free survival in early endometrial cancer.

G. Sutton, H. E. Geisler, F. Stehman, 1989 .

Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.

G. Sutton, W. Mcguire, J. Blessing, 1993, American journal of obstetrics and gynecology.

Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.

L. Einhorn, G. Sutton, J. Blessing, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.

G. Sutton, M. Markman, J. Hurteau, 1998, Gynecologic oncology.

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.

G. Sutton, J. Blessing, J. Malfetano, 1996, Gynecologic oncology.

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

P. Disaia, G. Sutton, J. Blessing, 1989, American journal of obstetrics and gynecology.

Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group study

G. Sutton, J. Blessing, R. Barrett, 1992 .

Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.

B. Sevin, G. Sutton, R. Zaino, 1992, American journal of obstetrics and gynecology.

Discovery and development of a novel class of nonsteroidal aromatase inhibitors

T. Lindstrom, N. Stamm, G. Sutton, 1987, Steroids.

Phase I Trial of Paclitaxel and Etoposide for Recurrent Ovarian Carcinoma: A Gynecologic Oncology Group Study

P. Fracasso, S. Baker, G. Sutton, 2000, American journal of clinical oncology.

Transforming growth factor‐β differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up‐regulation of p21WAF1

G. Sutton, R. Bigsby, J. Hurteau, 1999, Cancer.

Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study.

G. Sutton, H. Ball, J. Blessing, 1996, Gynecologic oncology.

Ovarian carcinoma: adjuvant treatment with P-32.

G. Sutton, N. Hornback, F. Stehman, 1987, Radiology.

Group B streptococcal necrotizing fasciitis arising from an episiotomy.

G. Sutton, J. Bennett, L. R. Smirz, 1985, Obstetrics and gynecology.

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

P. Fracasso, S. Waggoner, G. Sutton, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ifosfamide and mesna in epithelial ovarian carcinoma.

G. Sutton, 1993, Gynecologic oncology.

Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study).

E. Yordan, G. Sutton, B. Bundy, 1991, Gynecologic oncology.

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.

R. Wendt, D. Mutch, D. Podoloff, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.

G. Sutton, J. Blessing, R. Barrett, 1992, American journal of obstetrics and gynecology.

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.

G. Sutton, H. Homesley, J. Blessing, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.

G. Sutton, R. Park, H. Homesley, 1986, Cancer treatment reports.

Necrotizing Fasciitis of Vulvar Origin in Diabetic Patients

G. Sutton, C. Livengood, W. Addison, 1984, Obstetrics and gynecology.

A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancer.

G. Sutton, F. Stehman, A. Calkins, 1988, Gynecologic oncology.

Immunohistochemical Study of HER-2/neu, Epidermal Growth Factor Receptor, and Steroid Receptor Expression in Normal and Malignant Endometrium

G. Sutton, R. Bigsby, K. Look, 1992, Obstetrics and gynecology.

Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.

P. Disaia, G. Sutton, W. Mcguire, 1993, Gynecologic oncology.

Gynecologic Oncology Group experience with ifosfamide.

G. Sutton, H. Homesley, J. Blessing, 1990, Seminars in oncology.

Analysis of invasive squamous cell carcinoma of the vulva and vulnar intraepithelial neoplasia for the presence of human papillomavirus DNA

G. Sutton, K. Look, A. Roman, 1991, Obstetrics and gynecology.

Intraperitoneal 5-fluorouracil for pseudomyxoma peritoneii

G. Sutton, D. Moore, K. Look, 1992, International Journal of Gynecologic Cancer.

Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix

G. Sutton, J. Blessing, K. Webster, 1989, Investigational New Drugs.

A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.

G. Sutton, H. Homesley, J. Blessing, 1994, Gynecologic oncology.

Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients.

M. Callahan, G. Sutton, D. Reeves, 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Trends in the operative management of invasive squamous carcinoma of the vulva at Indiana University, 1974 to 1988.

G. Sutton, K. Look, F. Stehman, 1991, American journal of obstetrics and gynecology.

Adriamycin Chemotherapy for Malignant Mixed Mesodermal Tumor of the Ovary A Gynecologic Oncology Group Study

G. Sutton, B. Bundy, C. Morrow, 1986, American journal of clinical oncology.

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.

G. Sutton, H. Gallion, J. Kauderer, 2005, Gynecologic oncology.

Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease.

K. Hatch, G. Sutton, J. Soper, 1992, American journal of obstetrics and gynecology.

Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.

G. Sutton, H. Homesley, J. Blessing, 1989, Seminars in oncology.

Primary Yolk Sac Tumor of the Rectum

H. Michael, G. Sutton, K. Miller, 2000, Cancer investigation.

Human Papillomavirus Deoxyribonucleic Acid in Lesions of the Female Genital Tract: Evidence for Type 6/11 in Squamous Carcinoma of the Vulva

G. Sutton, F. Stehman, A. Roman, 1987, Obstetrics and gynecology.

Steroid secretion and testosterone binding in a woman with an ovarian hilus cell tumor and thyrotoxicosis.

G. Sutton, R. Wiebe, K. Lyles, 1981, American Journal of Obstetrics and Gynecology.

Endocrine changes at operation under general anesthesia: reproductive hormone fluctuations in young women.

G. Sutton, M. Soules, A. Haney, 1980, Fertility and sterility.

Urine GABA levels in ovarian cancer patients: elevated GABA in malignancy.

G. D. Guthrie, G. Sutton, J. Baenziger, 2001, Cancer letters.

Abdominal sacral colpopexy with Mersilene mesh in the retroperitoneal position in the management of posthysterectomy vaginal vault prolapse and enterocele.

G. Sutton, R. T. Parker, C. Livengood, 1985, American journal of obstetrics and gynecology.

Para-aortic nodal metastases in early cervical carcinoma: long-term survival following extended-field radiotherapy.

R. Brookland, S. Rubin, G. Sutton, 1983, Gynecologic oncology.

Collagenase expression in ovarian cancer cell lines.

G. Sutton, R. Bigsby, D. Moore, 1995, Gynecologic oncology.

A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery.

J. Schilder, G. Sutton, J. Hurteau, 1997, Gynecologic oncology.

Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results

R. Wendt, D. Mutch, D. Podoloff, 2003 .

Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.

J. Eble, G. Sutton, E. Oláh, 1992, Gynecologic oncology.

Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy.

T. Ulbright, G. Sutton, F. Stehman, 1985, Gynecologic oncology.

Chyloperitoneum following treatment for advanced gynecologic malignancies

J. P. Geisler, G. Sutton, R. Foster, 1994, Obstetrics and gynecology.

Gynecologic Oncology Group studies with ifosfamide.

G. Sutton, W. Mcguire, H. Homesley, 1992, Seminars in oncology.

Recurrent squamous carcinoma of the vulva

G. Sutton, N. Hornback, A. Tilmans, 1992, American journal of obstetrics and gynecology.

Flow cytometric analysis of DNA content and RAS P21 oncoprotein expression in ovarian neoplasms.

N. Fineberg, H. Michael, G. Sutton, 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.

G. Sutton, L. Demars, T. Burke, 1996, Gynecologic oncology.

Phase II trial of cisplatin as first‐line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

G. Sutton, J. Thigpen, W. Creasman, 1989, Gynecologic oncology.

Intrathecal Narcotic use in Gynecologic Oncology: Safety and Impact on Postoperative Length of Stay

G. Sutton, E. Moore, M. Isaacs, 2012 .

Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma.

G. Sutton, J. Guy, V. Purvin, 1999, Gynecologic oncology.

CASE REPORT Metastatic Choriocarcinoma Complicated by Term Pregnancy

G. Sutton, N. Rosenblum, J. Mikuta, 1989 .

Papillary serous carcinoma of the ovary with squamous differentiation.

T. Ulbright, G. Sutton, L. Roth, 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma.

G. Sutton, N. Prajda, D. Moore, 1997, Anticancer research.

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.

F M Muggia, G. Sutton, R. Alvarez, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Villous adenoma of the uterine cervix associated with invasive adenocarcinoma: a histologic, ultrastructural, and immunohistochemical study.

H. Michael, G. Sutton, M. T. Hull, 1986, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Villous adenoma of the uterine cervix associated with invasive adenocarcinoma: a histologic, ultrastructural, and immunohistochemical study

H. Michael, G. Sutton, M. T. Hull, 1986 .

Spontaneous Occurrence of Gangrene Due to Clostridium septicum in a Patient With Advanced Endometrial Carcinoma

G. Sutton, D. Moore, K. Ghosh, 1994, Infectious diseases in obstetrics and gynecology.

DNA content as a prognostic index in gestational trophoblastic neoplasia.

G. Sledge, T. Ulbright, G. Sutton, 1989, Gynecologic oncology.

The risk of nodal metastasis in early adenocarcinoma of the uterine cervix*

H. Michael, G. Sutton, J. Hurteau, 2003, International Journal of Gynecologic Cancer.

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Jubilee Brown, G. Sutton, M. Leitao, 2011, Gynecologic oncology.

Management of Uterine Sarcomas

G. Sutton, H. Gray, 2004 .

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.

G. Sutton, J. Sorosky, L. Kilgore, 2000, Gynecologic oncology.

Creation of a transverse colon--gastric composite reservoir: a new technique.

M. Adams, G. Sutton, R. Bihrle, 1989, The Journal of urology.

Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion.

J. P. Geisler, G. Sutton, K. Look, 1995, Gynecologic oncology.

Hormonal treatment of an endometrial stromal nodule followed by local excision.

J. Schilder, G. Sutton, W. Hurd, 1999, Obstetrics and gynecology.

Primary squamous cell carcinoma of the endometrium: Two cases and a review of the literature

G. Sutton, P. Rose, J. Broshears, 2013, Diagnostic cytopathology.

An intra-ovarian site for the luteolytic action of estrogen in the rhesus monkey.

G. Sutton, F. Karsch, 1976, Endocrinology.

Trisomy 21 associated with ovarian dysgerminoma.

G. Sutton, J. Hurteau, L. Roth, 1999, Gynecologic oncology.

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.

M. E. King, T. Roy, B. Mychalczak, 2005, Gynecologic oncology.

Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma

J. Wathen, R. Maki, S. George, 2013, Cancer.

Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.

T. Roy, G. Sutton, P. Gehrig, 2006, Gynecologic oncology.

Adjuvant treatment of high-risk primary uterine leiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D): Results of phase II multicenter trial SARC005.

R. Maki, S. George, G. Sutton, 2010 .

Estrogen and progesterone receptors in epithelial ovarian malignancies.

G. Sutton, J. Strauss, J. Mikuta, 1986, Gynecologic oncology.

Gynecologic cancers metastatic to the breast.

G. Sutton, J. Hurteau, D. Moore, 1998, Journal of the American College of Surgeons.

FIGO Stage IIIC Endometrial Carcinoma With Metastases Confined to Pelvic Lymph Nodes: Analysis of Treatment Outcomes, Prognostic Variables, and Failure Patterns Following Adjuvant Radiation Therapy

G. Sutton, J. Hurteau, M. Randall, 2000 .

Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.

C. Aghajanian, G. Sutton, K. Moxley, 2015, Gynecologic oncology.

Endoluminal radio-frequency electrocautery for permanent ureteral occlusion in swine.

K. Kopecky, R. Dreesen, J. Eble, 1989, Radiology.

Percutaneous transrenal endoureteral radio-frequency electrocautery for occlusion: case report.

K. Kopecky, G. Sutton, G. Becker, 1989, Radiology.

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer.

M. Callahan, G. Sutton, E. Eisenhauer, 2011, Gynecologic Oncology.

Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.

G. Sutton, F. Stehman, C. Ehrlich, 1988, American journal of obstetrics and gynecology.

Epithelioid hemangioendothelioma of the clitoris: a case report with immunohistochemical and ultrastructural findings.

G. Sutton, M. Yum, S. A. Strayer, 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Hormonal aspects of endometrial cancer.

G. Sutton, 1990, Current opinion in obstetrics & gynecology.

Hand-Assisted Robotic Surgery for Staging of Ovarian Cancer and Uterine Cancers With High Risk of Peritoneal Spread: A Retrospective Cohort Study

M. Callahan, G. Sutton, H. Fornalik, 2015, International Journal of Gynecologic Cancer.

Abdominal Wound Closure Using a Running, Looped Monofilament Polybutester Suture: Comparison to Smead–Jones Closure in Historic Controls

G. Sutton, S. Morgan, 1992, Obstetrics and gynecology.

The fate of the ovaries after radical hysterectomy and ovarian transposition.

G. Sutton, D. Moore, K. Look, 1995, Gynecologic oncology.

Life-threatening hemorrhage complicating sacral colpopexy.

G. Sutton, C. Livengood, C. Hammond, 1981, American journal of obstetrics and gynecology.

Malignant degeneration of a mature cystic teratoma five decades after discovery.

G. Sutton, K. Look, J. Wass, 1995, Gynecologic oncology.

Collagenase expression in ovarian cancer cell lines.

G. Sutton, R. Bigsby, D. Moore, 1995, Gynecologic oncology.

Reply to Dr. Frederic Amant

G. Sutton, 2005 .

Adenocarcinoma corpus et colli: analysis of diagnostic variables.

G. Sutton, N. Hornback, F. Stehman, 1986, International journal of radiation oncology, biology, physics.

GROWING TERATOMA SYNDROME AFTER CHEMOTHERAPY FOR GERM CELL TUMORS OF THE OVARY

J. P. Geisler, G. Sutton, R. Foster, 1994, Obstetrics and gynecology.

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum‐resistant ovarian cancer and primary peritoneal carcinomatosis

D. Matei, J. Schilder, C. Whalen, 2008, Cancer.

Aggressive angiomyxoma first diagnosed as levator hernia.

G. Sutton, R. Rogers, C. Ehrlich, 1989, American journal of obstetrics and gynecology.

Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

G. Sutton, J. Blessing, R. Barrett, 1994, Gynecologic oncology.

Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma: A phase II study of the Gynecologic Oncology Group

K. Hatch, G. Sutton, H. Muss, 1985, American journal of clinical oncology.

Phase II study of Ifosfamide and Mesna in refractory adenocarcinoma of the endometrium

G. Sutton, W. Mcguire, H. Homesley, 1994, Cancer.

Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.

D. Matei, S. Perkins, J. Schilder, 2009, Gynecologic oncology.

Malignant papillary lesions of the endometrium.

H. Michael, G. Sutton, F. Stehman, 1987, Gynecologic oncology.

Splitting hairs about splitting muscles.

G. Sutton, 1991, American journal of obstetrics and gynecology.

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

B. Monk, R. Coleman, C. Aghajanian, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of vinblastine in advanced ovarian carcinoma

G. Sutton, J. Blessing, M. Adelson, 1990, Investigational New Drugs.

Epithelial ovarian cancer complicating renal transplantation.

G. Sutton, D. Moore, K. Ghosh, 1994, American journal of obstetrics and gynecology.

Ovarian carcinoma with extracellular mucin production: reassessment of "pseudomyxoma ovarii et peritonei".

H. Michael, G. Sutton, L. Roth, 1987, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Second-look laparotomy after chemotherapy in the management of ovarian malignancy.

T. Ulbright, G. Sutton, F. Stehman, 1985, American journal of obstetrics and gynecology.

Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies

G. Sutton, H. Homesley, J. Blessing, 2004, Cancer Chemotherapy and Pharmacology.

Phase II Study of Vinblastine in Previously Treated Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

G. Sutton, H. Ball, J. Blessing, 1990, American journal of clinical oncology.

Retroperitoneal leiomyosarcoma: eight cases and a literature review.

H. Michael, G. Sutton, C. Todd, 1995, Gynecologic oncology.

Estrogen and Progesterone Receptors in Uterine Sarcomas

H. Michael, G. Sutton, F. Stehman, 1986, Obstetrics and gynecology.

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

A. Godwin, A. Sood, C. Drescher, 2012, Gynecologic oncology.

Blood transfusion and the risk of recurrence in squamous carcinoma of the vulva.

G. Sutton, K. Look, F. Stehman, 1993, American journal of obstetrics and gynecology.

The Importance of Peritoneal Cytology in Endometrial Carcinoma

G. Sutton, S. Clark, V. Harouny, 1988, Obstetrics and gynecology.

Surgical staging of carcinoma of the ovaries.

G. Sutton, M. Brady, W. Hoskins, 1989, Surgery, gynecology & obstetrics.